These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34665836)

  • 1. Fabrication, in vitro and ex vivo evaluation of proliposomes and liposomal derived gel for enhanced solubility and permeability of diacerein.
    Shah H; Madni A; Rahim MA; Jan N; Khan A; Khan S; Jabar A; Ali A
    PLoS One; 2021; 16(10):e0258141. PubMed ID: 34665836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery.
    Jukanti R; Sheela S; Bandari S; Veerareddy PR
    J Pharm Sci; 2011 Aug; 100(8):3208-3222. PubMed ID: 21404279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System.
    Nekkanti V; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diacerein solid dispersion loaded tablets for minimization of drug adverse effects: statistical design, formulation,
    Soliman MAN; Ibrahim HK; Nour SAE
    Pharm Dev Technol; 2021 Mar; 26(3):302-315. PubMed ID: 33356729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects.
    Jain A; Singh SK; Singh Y; Singh S
    J Biomed Nanotechnol; 2013 May; 9(5):891-900. PubMed ID: 23802421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
    Aziz DE; Abdelbary AA; Elassasy AI
    Curr Drug Deliv; 2018; 15(9):1330-1342. PubMed ID: 29921206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine.
    Hiremath PS; Soppimath KS; Betageri GV
    Int J Pharm; 2009 Oct; 380(1-2):96-104. PubMed ID: 19616608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capped flexosomes for prominent anti-inflammatory activity: development, optimization, and ex vivo and in vivo assessments.
    Ahmed S; Aziz DE; Sadek MA; Tawfik MA
    Drug Deliv Transl Res; 2024 Sep; 14(9):2474-2487. PubMed ID: 38315262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge.
    Janga KY; Jukanti R; Velpula A; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR
    Eur J Pharm Biopharm; 2012 Feb; 80(2):347-57. PubMed ID: 22041602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren Hemifumarate Proliposomes for Improved Oral Drug Delivery: Formulation Development, In Vitro and In Vivo Permeability Testing.
    Kunamaneni P; Kovvasu S; Yeung S; Wang J; Shah S; Betageri G
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Oct; 17(5):1019-29. PubMed ID: 26729532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine.
    Bi Y; Lv B; Li L; Lee RJ; Xie J; Qiu Z; Teng L
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31947655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery.
    Bobbala SK; Veerareddy PR
    J Liposome Res; 2012 Dec; 22(4):285-94. PubMed ID: 22762199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future drug delivery research in South Korea.
    Chung SJ
    J Control Release; 1999 Nov; 62(1-2):73-9. PubMed ID: 10518638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal gels for site-specific, sustained delivery of celecoxib: in vitro and in vivo evaluation.
    Fetih G; Fathalla D; El-Badry M
    Drug Dev Res; 2014 Jun; 75(4):257-66. PubMed ID: 24939834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein.
    Eltobshi AA; Mohamed EA; Abdelghani GM; Nouh AT
    Int J Nanomedicine; 2018; 13():6585-6602. PubMed ID: 30425476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced transdermal permeation and anti-inflammatory potential of phospholipids complex-loaded matrix film of umbelliferone: Formulation development, physico-chemical and functional characterization.
    Telange DR; Nirgulkar SB; Umekar MJ; Patil AT; Pethe AM; Bali NR
    Eur J Pharm Sci; 2019 Apr; 131():23-38. PubMed ID: 30735820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000.
    Aggarwal AK; Singh S
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1181-91. PubMed ID: 21449824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.